Navigation Links
Recycling industrial waste water
Date:4/16/2014

A research group composed of Dr. Martin Prechtl, Leo Heim and their colleagues at the University of Cologne's Department of Chemistry has discovered a new method of generating hydrogen using water and formaldehyde. The generation of hydrogen from liquids is of particular interest when it comes to fuel cell technologies. The results of the project, entitled "Selective and mild hydrogen production using water and formaldehyde", have recently been published in the journal Nature Communications.

Among other applications, the new approach can be used to recycle industrial waste water contaminated by formaldehyde to break down the contaminants whilst simultaneously generating hydrogen. With the aid of this method, it is possible to reclaim an important raw material from industrial waste water. Prechtl and his colleagues have also identified an air-stable and robust catalyst that can be employed with the technique. The researchers have already filed a corresponding patent application.

Formaldehyde is one of the most important raw materials used in chemical engineering; around 30 million tonnes of the substance are produced annually around the world. It is therefore available as a source of hydrogen in large quantities and at low cost.
'/>"/>

Contact: Dr. Martin Prechtl
martin.prechtl@uni-koeln.de
49-221-470-1981
University of Cologne
Source:Eurekalert

Page: 1

Related biology news :

1. Humans were already recycling 13,000 years ago
2. South Africas Capitec Bank Chooses Diebold Cash Recycling ATMs
3. Blind flies without recycling
4. More emphasis needed on recycling and reuse of Li-ion batteries
5. Gold nanoparticles give an edge in recycling CO2
6. Recycling valuable materials used in TVs, car batteries, cell phones
7. Historic blaze fueled a boom in tire recycling, advances in fire monitoring
8. New textbook tackles the sustainable recycling of manure
9. Enlisting cells protein recycling machinery to regulate plant products
10. Poisoning from industrial compounds can cause similar effects to ALS
11. US Navy defends renewable fuels strategy in Industrial Biotechnology Journal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:4/14/2016)... AVIV, Israel , April 14, 2016 ... Behavioral Authentication and Malware Detection, today announced the appointment ... already assumed the new role. Goldwerger,s leadership ... BioCatch, on the heels of the deployment of its ... addition, BioCatch,s behavioral biometric technology, which discerns unique cognitive ...
(Date:3/31/2016)...   LegacyXChange, Inc. ... LegacyXChange is excited to release its first ... be launched online site for trading 100% guaranteed authentic ... also provide potential shareholders a sense of the value ... industry that is notorious for fraud. The video is ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial ... Cary 5000 and the 6000i models are higher end machines that use the more ... the spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... 23, 2016  The Biodesign Challenge (BDC), a university ... to harness living systems and biotechnology, announced its winning ... New York City . ... showcased projects at MoMA,s Celeste Bartos Theater during the ... MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: